Aperam Shares Drop 8.46% Following Downgrade by JP Morgan

JP Morgan Adjusts Its Stance on Aperam

This Monday, American bank JP Morgan altered its recommendation for Aperam, shifting from 'overweight' to 'neutral'. The price target was simultaneously reduced from 45.10 euros to 40.70 euros, still representing a potential revaluation of about 19% compared to the current price of 34.20 euros. This downgrade comes as the stock has shown a marked decline of 23% over the past seven days, significantly erasing gains accumulated over the previous three months (+4.08%). Over the past year, the performance remains positive at 7.08%, but the recent trend illustrates a sharp reversal in the group's stock trajectory.

Technical Analysis of Aperam's Stock

Technically, Aperam's stock price has significantly fallen below its support level at 35.44 euros, a downward breach that reflects the strength of the selling movement. The stock is now trading below its 50-day moving average (38.29 euros) and has also moved significantly away from its 20-day moving average (42.11 euros), confirming a short-term bearish acceleration. Only the 200-day moving average, at 31.29 euros, remains below the current price, providing a potential reference point should the decline continue. The RSI, an indicator measuring the relative strength of the stock, is at 36, approaching the oversold zone typically set at 30. This level indicates high selling pressure, though it does not guarantee an imminent rebound. The monthly volatility, measured at 20.97%, remains high and reflects the unusual amplitude of recent movements in the stock. The overall market environment continues to be tense, as evidenced by a 12.29% increase in the VIX as of the last available measurement on March 5.